ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years
Zhichen Jiang
Matched on ORCID iD 0000-0002-7489-580X; OpenAlex author ID A5015628998. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2022: 1 paper · 2023: 5 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 8
- 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.acra.2025.10.024↗
- CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Val… Co-author DOI 10.1155/humu/7359548↗
- Correction: Functions and clinical applications of exosomes in Pancreatic cancer. Co-author DOI 10.1007/s11033-023-08906-3↗
- Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Co-author DOI 10.1007/s11684-023-1050-6↗
- Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. Co-author DOI 10.1186/s12885-023-11493-y↗
- The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review. Co-author DOI 10.7150/jca.79171↗
- Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell infiltration through CCL5-CCR5 axis. Co-author PMID 38058826↗
- Functions and clinical applications of exosomes in pancreatic cancer. Co-author DOI 10.1007/s11033-022-07765-8↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weiwei Jin · 6 shared papers, 2022–2026 · strength 1.38
- Paper 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.acra.2025.10.024↗
- Paper CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian … DOI 10.1155/humu/7359548↗
- Paper Correction: Functions and clinical applications of exosomes in Pancreatic cancer. DOI 10.1007/s11033-023-08906-3↗
- Yiping Mou · 5 shared papers, 2022–2026 · strength 1.11
- Paper 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.acra.2025.10.024↗
- Paper Correction: Functions and clinical applications of exosomes in Pancreatic cancer. DOI 10.1007/s11033-023-08906-3↗
- Paper Functions and clinical applications of exosomes in pancreatic cancer. DOI 10.1007/s11033-022-07765-8↗
- Hui‐Ju Wang · 5 shared papers, 2022–2023 · strength 1.02
- Paper Correction: Functions and clinical applications of exosomes in Pancreatic cancer. DOI 10.1007/s11033-023-08906-3↗
- Paper The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review. DOI 10.7150/jca.79171↗
- Paper Functions and clinical applications of exosomes in pancreatic cancer. DOI 10.1007/s11033-022-07765-8↗
- Mingyang Liu · 3 shared papers, 2023 · strength 0.63
- Paper Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challeng… DOI 10.1007/s11684-023-1050-6↗
- Paper Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. DOI 10.1186/s12885-023-11493-y↗
- Paper Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell … PMID 38058826↗
- Xiaohao Zheng · 2 shared papers, 2023 · strength 0.44
- J J Chen · 1 shared paper, 2026 · strength 0.30
- Yuanyu Wang · 1 shared paper, 2026 · strength 0.27
- Min Li · 1 shared paper, 2023 · strength 0.26
- Cen-Cen Sun · 1 shared paper, 2023 · strength 0.22
- Li Li · 1 shared paper, 2023 · strength 0.22
- Liang Wang · 1 shared paper, 2023 · strength 0.22
- Li Li · 1 shared paper, 2023 · strength 0.19
- Shaobo Zhang · 1 shared paper, 2023 · strength 0.17
- Fangxia Wang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.